Filing Details
- Accession Number:
- 0001615774-18-004510
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-30 16:05:18
- Reporting Period:
- 2018-05-25
- Accepted Time:
- 2018-05-30 16:05:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1430306 | Tonix Pharmaceuticals Holding Corp. | TNXP | Pharmaceutical Preparations (2834) | 261434750 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1563420 | Seth Lederman | C/O Tonix Pharmaceuticals Holding Corp. 509 Madison Avenue, Suite 306 New York NY 10022 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value | Acquisiton | 2018-05-25 | 4,000 | $3.17 | 26,700 | No | 4 | P | Indirect | By 401(k) plan |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By 401(k) plan |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.001 Par Value | 11,166 | Direct | |
Common Stock, $0.001 Par Value | 45,900 | Indirect | By IRA account |
Common Stock, $0.001 Par Value | 3,100 | Indirect | By spouse |
Common Stock, $0.001 Par Value | 3 | Indirect | By Leder Laboratories, Inc |
Common Stock, $0.001 Par Value | 3 | Indirect | By Starling Pharmaceuticals, Inc. |
Common Stock, $0.001 Par Value | 18,463 | Indirect | By Lederman & Co., LLC |
Common Stock, $0.001 Par Value | 3,246 | Indirect | By L&L Technologies, LLC |
Common Stock, $0.001 Par Value | 5,898 | Indirect | By Targent Pharmaceuticals, LLC |